Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-007308
Filing Date
2024-09-20
Accepted
2024-09-20 17:37:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3262
  Complete submission text file 0001950047-24-007308.txt   4696
Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ. BLDG. 1400E SUITE B14202 CAMBRIDGE MA 02139
Business Address
Donovan Joanne M. (Reporting) CIK: 0001644087 (see all company filings)

Type: 144

Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Subject) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40236 | Film No.: 241314259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)